264 related articles for article (PubMed ID: 14573732)
1. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease.
Blankenberg S; Rupprecht HJ; Bickel C; Torzewski M; Hafner G; Tiret L; Smieja M; Cambien F; Meyer J; Lackner KJ;
N Engl J Med; 2003 Oct; 349(17):1605-13. PubMed ID: 14573732
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant enzyme activity and coronary heart disease: meta-analyses of observational studies.
Flores-Mateo G; Carrillo-Santisteve P; Elosua R; Guallar E; Marrugat J; Bleys J; Covas MI
Am J Epidemiol; 2009 Jul; 170(2):135-47. PubMed ID: 19465742
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
Ridker PM; Hennekens CH; Buring JE; Rifai N
N Engl J Med; 2000 Mar; 342(12):836-43. PubMed ID: 10733371
[TBL] [Abstract][Full Text] [Related]
4. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
[TBL] [Abstract][Full Text] [Related]
5. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
[TBL] [Abstract][Full Text] [Related]
7. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
[TBL] [Abstract][Full Text] [Related]
9. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study.
Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Bickel C; Lackner KJ; Cambien F; Tiret L; Münzel T; Blankenberg S
J Am Coll Cardiol; 2006 Feb; 47(3):552-8. PubMed ID: 16458135
[TBL] [Abstract][Full Text] [Related]
10. Circulating endothelial progenitor cells and cardiovascular outcomes.
Werner N; Kosiol S; Schiegl T; Ahlers P; Walenta K; Link A; Böhm M; Nickenig G
N Engl J Med; 2005 Sep; 353(10):999-1007. PubMed ID: 16148285
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH
Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
13. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study.
Schnabel R; Rupprecht HJ; Lackner KJ; Lubos E; Bickel C; Meyer J; Münzel T; Cambien F; Tiret L; Blankenberg S;
Eur Heart J; 2005 Feb; 26(3):241-9. PubMed ID: 15618051
[TBL] [Abstract][Full Text] [Related]
14. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
[TBL] [Abstract][Full Text] [Related]
15. Serum albumin predicts cardiac adverse events in patients with advanced atherosclerosis - interrelation with traditional cardiovascular risk factors.
Schillinger M; Exner M; Mlekusch W; Amighi J; Sabeti S; Schlager O; Wagner O; Minar E
Thromb Haemost; 2004 Mar; 91(3):610-8. PubMed ID: 14983239
[TBL] [Abstract][Full Text] [Related]
16. Activity of CuZn-superoxide dismutase, catalase and glutathione peroxidase in erythrocytes in kidney allografts during reperfusion in patients with and without delayed graft function.
Domański L; Dołegowska B; Safranow K; Rózański J; Myślak M; Romanowski M; Sieńko J; Sulikowski T; Ostrowski M; Kedzierska K; Domański M; Chlubek D; Pawlik A; Ciechanowski K
Clin Transplant; 2006; 20(1):67-71. PubMed ID: 16556156
[TBL] [Abstract][Full Text] [Related]
17. Serum cholesterol in young men and subsequent cardiovascular disease.
Klag MJ; Ford DE; Mead LA; He J; Whelton PK; Liang KY; Levine DM
N Engl J Med; 1993 Feb; 328(5):313-8. PubMed ID: 8419817
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease.
Blankenberg S; Rupprecht HJ; Poirier O; Bickel C; Smieja M; Hafner G; Meyer J; Cambien F; Tiret L;
Circulation; 2003 Apr; 107(12):1579-85. PubMed ID: 12668489
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory markers and the risk of coronary heart disease in men and women.
Pai JK; Pischon T; Ma J; Manson JE; Hankinson SE; Joshipura K; Curhan GC; Rifai N; Cannuscio CC; Stampfer MJ; Rimm EB
N Engl J Med; 2004 Dec; 351(25):2599-610. PubMed ID: 15602020
[TBL] [Abstract][Full Text] [Related]
20. Reduction in plasma total homocysteine through increasing folate intake in healthy individuals is not associated with changes in measures of antioxidant activity or oxidant damage.
Moat SJ; Hill MH; McDowell IF; Pullin CH; Ashfield-Watt PA; Clark ZE; Whiting JM; Newcombe RG; Lewis MJ; Powers HJ
Eur J Clin Nutr; 2003 Mar; 57(3):483-9. PubMed ID: 12627187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
